GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 96 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,085,000 | -77.2% | 500,000 | -47.4% | 0.49% | -74.8% |
| Q3 2017 | $9,149,000 | -6.3% | 950,000 | +15.2% | 1.94% | -4.2% |
| Q2 2017 | $9,760,000 | +17.1% | 825,000 | +26.9% | 2.03% | +30.7% |
| Q1 2017 | $8,333,000 | +427.1% | 650,000 | +116.7% | 1.55% | +73.5% |
| Q1 2016 | $1,581,000 | -50.3% | 300,000 | -26.8% | 0.90% | -31.3% |
| Q4 2015 | $3,182,000 | -23.0% | 410,000 | -21.9% | 1.30% | -29.9% |
| Q3 2015 | $4,132,000 | -39.2% | 525,000 | -30.0% | 1.86% | -15.5% |
| Q2 2015 | $6,795,000 | +169.1% | 750,000 | +294.7% | 2.20% | +41.8% |
| Q4 2013 | $2,525,000 | – | 190,000 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|